Tune in to Patients
Henry Ginsberg, MD
Professor of Medicine, Columbia University, past Director, Irving Institute for Clinical & Translational Research, senior investigator of cardiovascular disease and lipoprotein metabolism research, member of Silence Therapeutics’ Scientific Advisory Board.
In his late 40s, Dr. Ginsberg discovered that he had a slightly high coronary calcium score, a test that looks for calcium deposits in the heart’s major arteries, which signifies the presence of coronary artery plaques. Dr. Ginsberg’s blood lipid levels, including LDL cholesterol, had always been in the normal range and he had no other personal risk factors for cardiovascular disease.
There was, however, a history of early coronary heart disease on his mother’s side and stroke and aortic stenosis on his father’s side.